This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignee: University of California. Active years: 2009-2015.
Company Filing History:
Years Active: 2009-2015
Title: Innovations of S Paul Bajaj in the Field of Biochemistry
Introduction
S Paul Bajaj is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of biochemistry, particularly in the area of plasmin inhibition. With a total of 2 patents, his work has implications for medical advancements and therapeutic applications.
Latest Patents
Bajaj's latest patents include "Methods and compositions related to mutant Kunitz domain I of TFPI-2," which discloses methods and compositions relating to plasmin inhibition. Another significant patent is "Human kunitz-type inhibitor with enhanced antifibrinolytic activity," which describes a human Kunitz-type inhibitor polypeptide with enhanced antifibrinolytic activity. This novel polypeptide is structurally similar to the KD1 domain of human tissue factor pathway inhibitor-2 (TFPI-2).
Career Highlights
S Paul Bajaj is affiliated with the University of California, where he continues to engage in research and innovation. His work has been instrumental in advancing the understanding of Kunitz-type inhibitors and their potential applications in medicine.
Collaborations
Some of his notable coworkers include Walter Kisiel and Hitendra S Chand, who have collaborated with him on various research projects.
Conclusion
S Paul Bajaj's contributions to biochemistry through his patents and research at the University of California highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical science.